Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "TheraNym"

2 News Found

Aurobindo Pharma launches TheraNym, India’s largest biologics CMO
Biopharma | June 05, 2026

Aurobindo Pharma launches TheraNym, India’s largest biologics CMO

MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market

Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD
Biopharma | April 16, 2026

Aurobindo’s TheraNym to invest up to $175 million in expanded biologics deal with MSD

TheraNym will set up a greenfield large-scale mammalian drug substance manufacturing facility

Upcoming E-conference
June 19, 2026 The Future of Clinical Research in India: Can India Become a Global Trial Hub?
July 17, 2026 Biosimilars & Biologics: The Next Growth Frontiers for Indian Pharma

Latest Stories

Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies

Aurobindo Pharma receives USFDA nod for generic Tofacitinib tablets

Suven Life reports positive interim review for phase 3 Alzheimer’s therapy

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India’s medical devices sector is poised for a pharma-like transformation: Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech
India’s medical devices sector is poised for a pharma-like transformation: Pranav Sharma, SBU Head - Advanced Surgery, Healthium MedTech
Pranav Sharma Strategic Business Unit Head - Advance Surgery, Healthium MedTech
Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India
Expanding our technical portfolio with advanced ICP-OES Series to boost India's analytical capabilities: Santosh Kumar, Managing Director, Analytik Jena India
Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences
Empowering life sciences and diagnostics with balanced, scalable technologies: Dev Ananthan, Director of Strategic Marketing, Danaher Lifesciences

Packaging